A group of scientists from a Canadian firm have developed a drug that targets specific proteins in the brain and stops Alzheimer’s in its tracks.
Early tests show the drug halts chemical processes that kill brain cells and proves to be beneficial against short term memory loss as well.
What really sets it apart, however, is that it has no damaging side effects.
Gene Williams, of pro MIS, the firm behind the drug stated to a popular website that the drug is like a ninja because it only targets toxic parts. He went on to add that if one stops the process that kills brain cells, it actually gives the brain a chance to kick in and work, showing a reversal of symptoms.
The drug — PMN310 antibody — works by neutralising harmful proteins so the brain can clear them out naturally.
The study which has been successful on mice, only means that it will now be trialled in humans and may soon be available by 2025.